Humedix Co., Ltd. (KOSDAQ:200670)
South Korea · Delayed Price · Currency is KRW 26,300
+100 (0.38%)
Jun 10, 2026, 3:30 PM KST
Humedix Market Cap
Humedix has a market cap or net worth of 270.39 billion as of June 10, 2026. Its market cap has decreased by -37.77% in one year.
Market Cap
270.39B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
27.18
Stock Price
26,300.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 270.39B, an increase of 21.24%. That is a compound annual growth rate of 1.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 270.39B | -35.07% |
| Dec 30, 2025 | 416.42B | -4.39% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Huons Global | 334.97B |
| EuBiologics | 330.14B |
| JW Holdings | 250.47B |
| Korea United Pharm | 250.07B |
| FutureChem Co.,Ltd | 243.73B |
| Samjin Pharmaceuticals | 229.10B |
| Yungjin Pharm. | 227.15B |
| Daewon Pharmaceutical | 225.91B |